Anti-Peptic Ulcer Drugs Market 2022 Growth, COVID Impact, Trends Analysis Report 2028
The global anti-peptic ulcer drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Anti-peptic ulcer drugs are among the various classes of drugs with different action mechanisms used to treat or reduce peptic ulcers or irritation of the gastrointestinal tract. Further, H. pylori, the spiral-shaped bacteria can damage the stomach and duodenum lining and cause peptic ulcer disease. The market growth is majorly attributed to the exceptionally growing prevalence of peptic ulcers all over the globe. As per the National Institutes of Health (NIH), about 30 to 40% of people in the US get an H. pylori infection. In most cases, the infection remains dormant, or quiet without signs or symptoms, for years. Most people get an H. pylori infection as a child.
To Request a Sample of our Report on Anti-Peptic Ulcer
Drugs Market: https://www.omrglobal.com/request-sample/anti-peptic-ulcer-drugs-market
Another key trend observed in the market includes the
growing preference of patients toward peptic ulcer drugs over surgeries. This
is anticipated to be a major factor to augment the global anti-peptic ulcer
drugs market during the forecast period. In addition to this, the increasing
focus of the key players of the market on the research and development
activities coupled with the rising number of generic drugs manufacturers of
peptic ulcer drugs are also likely to offer lucrative opportunities for market
growth. Further, stressed lifestyles, as well as a significant rise in the
patient pool with H. pylori infection, will also raise the demand for these
drugs in the future years.
Market Coverage
• The
market number available for – 2021-2028
• Base
year- 2021
• Forecast
period- 2022-2028
Segment Covered-
·
By Product Type
·
By Application
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape: AstraZeneca
plc, and Takeda Pharmaceutical Co., Ltd., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Anti-Peptic Ulcer Drugs Market is Available @ https://www.omrglobal.com/industry-reports/anti-peptic-ulcer-drugs-market
Global Anti-Peptic Ulcer Drugs Market Report by Segment
By Product Type
• Proton
Pump Inhibitors
• Antacids
• Potassium-Competitive
Acid Blockers (P-CAB)
• H2
Antagonist
• Others
By Application
• Gastritis
• Gastric
Ulcers
• Duodenal
Ulcers
• Gastroesophageal
Reflux Disease (GERD)
Global Anti-Peptic Ulcer Drugs Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment